bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Сен. 27, 2024
As
the
most
common
subtype
of
dementia,
Alzheimer's
disease
(AD)
is
characterized
by
a
progressive
decline
in
cognitive
functions,
especially
memory,
thinking,
and
reasoning
ability.
Early
diagnosis
interventions
enable
implementation
measures
to
reduce
or
slow
further
regression
disease,
preventing
individuals
from
severe
brain
function
decline.
The
current
framework
AD
depends
on
A/T/(N)
biomarkers
detection
cerebrospinal
fluid
imaging
data,
which
invasive
expensive
during
data
acquisition
process.
Moreover,
pathophysiological
changes
accumulate
amino
acids,
metabolism,
neuroinflammation,
etc.,
resulting
heterogeneity
newly
registered
patients.
Recently,
next
generation
sequencing
(NGS)
technologies
have
found
be
non-invasive,
efficient
less-costly
alternative
screening.
However,
existing
studies
rely
single
omics
only.
To
address
these
concerns,
we
introduce
WIMOAD,
weighted
integration
multi-omics
for
diagnosis.
WIMOAD
synergistically
leverages
specialized
classifiers
patients'
paired
gene
expression
methylation
multi-stage
classification.
scores
were
then
stacked
with
MLP-based
meta-models
performance
improvement.
prediction
results
two
distinct
integrated
optimized
weights
final
decision-making
model,
providing
higher
than
using
Remarkably,
achieves
significantly
alone
classification
tasks.
model's
overall
also
outperformed
approaches,
highlighting
its
ability
effectively
discern
intricate
patterns
their
correlations
clinical
results.
In
addition,
stands
out
as
biologically
interpretable
model
leveraging
SHapley
Additive
exPlanations
(SHAP)
elucidate
contributions
each
output.
We
believe
very
promising
tool
accurate
effective
biomarker
discovery
across
different
progression
stages,
eventually
will
consequential
impacts
early
treatment
intervention
personalized
therapy
design
AD.
Computers in Biology and Medicine,
Год журнала:
2024,
Номер
177, С. 108635 - 108635
Опубликована: Май 22, 2024
Multimodal
medical
imaging
plays
a
pivotal
role
in
clinical
diagnosis
and
research,
as
it
combines
information
from
various
modalities
to
provide
more
comprehensive
understanding
of
the
underlying
pathology.
Recently,
deep
learning-based
multimodal
fusion
techniques
have
emerged
powerful
tools
for
improving
image
classification.
This
review
offers
thorough
analysis
developments
classification
tasks.
We
explore
complementary
relationships
among
prevalent
outline
three
main
schemes
networks:
input
fusion,
intermediate
(encompassing
single-level
hierarchical
attention-based
fusion),
output
fusion.
By
evaluating
performance
these
techniques,
we
insight
into
suitability
different
network
architectures
scenarios
application
domains.
Furthermore,
delve
challenges
related
architecture
selection,
handling
incomplete
data
management,
potential
limitations
Finally,
spotlight
promising
future
Transformer-based
give
recommendations
research
this
rapidly
evolving
field.
Computer Methods and Programs in Biomedicine,
Год журнала:
2024,
Номер
254, С. 108259 - 108259
Опубликована: Июнь 6, 2024
Alzheimer's
disease
(AD)
is
a
dreaded
degenerative
that
results
in
profound
decline
human
cognition
and
memory.
Due
to
its
intricate
pathogenesis
the
lack
of
effective
therapeutic
interventions,
early
diagnosis
plays
paramount
role
AD.
Recent
research
based
on
neuroimaging
has
shown
application
deep
learning
methods
by
multimodal
neural
images
can
effectively
detect
However,
these
only
concatenate
fuse
high-level
features
extracted
from
different
modalities,
ignoring
fusion
interaction
low-level
across
modalities.
It
consequently
leads
unsatisfactory
classification
performance.
In
this
paper,
we
propose
novel
multi-scale
attention
cross-enhanced
network,
MACFNet,
which
enables
multi-stage
between
inputs
learn
shared
feature
representations.
We
first
construct
Cross-Enhanced
Fusion
Module
(CEFM),
fuses
modalities
through
cross-structure.
addition,
an
Efficient
Spatial
Channel
Attention
(ECSA)
module
proposed,
able
focus
important
AD-related
more
efficiently
achieve
enhancement
two-stage
residual
concatenation.
Finally,
also
multiscale
guiding
block
(MSAG)
dilated
convolution,
obtain
rich
receptive
fields
without
increasing
model
parameters
computation,
improve
efficiency
extraction.
Experiments
Disease
Neuroimaging
Initiative
(ADNI)
dataset
demonstrate
our
MACFNet
better
performance
than
existing
methods,
with
accuracies
99.59%,
98.85%,
99.61%,
98.23%
for
AD
vs.
CN,
MCI,
CN
MCI
respectively,
specificity
98.92%,
97.07%,
99.58%
99.04%,
sensitivity
99.91%,
99.89%,
99.63%
97.75%,
respectively.
The
proposed
high-accuracy
diagnostic
framework.
Through
cross
mechanism
efficient
attention,
make
full
use
modal
medical
pay
local
global
information
images.
This
work
provides
valuable
reference
multi-mode
diagnosis.
Alzheimer's
disease
(AD)
is
a
chronic
and
irreversible
neurological
disorder,
making
early
detection
essential
for
managing
its
progression.This
study
investigates
the
coherence
of
SHAP
values
with
medical
scientific
truth.It
examines
three
types
features:
clinical,
demographic,
FreeSurfer
extracted
from
MRI
scans.A
set
six
ML
classifiers
are
investigated
their
interpretability
levels.This
validated
on
OASIS-3
dataset
binary
classification.The
results
show
that
clinical
data
outperforms
others,
margin
14%
over
features,
second-best
features.In
case
explanations
provided
by
tree-based
consistently
align
insights.This
comparison
was
calculated
using
Kendall
Tau
distance.
Health Science Reports,
Год журнала:
2025,
Номер
8(5)
Опубликована: Май 1, 2025
ABSTRACT
Purpose
Alzheimer's
disease
(AD)
is
a
severe
neurological
that
significantly
impairs
brain
function.
Timely
identification
of
AD
essential
for
appropriate
treatment
and
care.
This
comprehensive
review
intends
to
examine
current
developments
in
deep
learning
(DL)
approaches
with
neuroimaging
diagnosis,
where
popular
imaging
types,
reviews
well‐known
online
accessible
data
sets,
describes
different
algorithms
used
DL
the
correct
initial
evaluation
are
presented.
Significance
Conventional
diagnostic
techniques,
including
medical
evaluations
cognitive
assessments,
usually
not
identify
stages
Alzheimer's.
Neuroimaging
methods,
when
integrated
have
demonstrated
considerable
potential
enhancing
diagnosis
categorization
AD.
models
received
significant
interest
due
their
capability
its
early
phases
automatically,
which
reduces
mortality
rate
cost
Method
An
extensive
literature
search
was
performed
leading
scientific
databases,
concentrating
on
papers
published
from
2021
2025.
Research
leveraging
techniques
such
as
magnetic
resonance
(MRI),
positron
emission
tomography,
functional
(fMRI),
so
forth.
The
complies
Preferred
Reporting
Items
Systematic
Reviews
Meta‐Analyses
(PRISMA)
guidelines.
Results
Current
show
CNN‐based
especially
those
utilizing
hybrid
transfer
frameworks,
outperform
conventional
methods.
employing
combination
multimodal
has
enhanced
precision.
Still,
challenges
method
interpretability,
heterogeneity,
limited
exist
issues.
Conclusion
considerably
improved
accuracy
reliability
neuroimaging.
Regardless
issues
accessibility
adaptability,
studies
into
interpretability
fusion
provide
clinical
application.
Further
research
should
concentrate
standardized
rigorous
validation
architectures,
understandable
AI
methodologies
enhance
effectiveness
methods
prediction.